Search Results 221-230 of 18544 for Relapse
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation ...
Educational and relapse-prevention group sessions. Process group psychotherapy sessions. Individual counseling. Friday family day (every other Friday) ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
The purpose of this study is to determine the maximum tolerated dose (MTD) of KO-539, a menin-MLL(KMT2A) inhibitor, in patients with refractory or relapsed ...
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma · Overview · Participation eligibility.
Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 ... Inadequate response,relapse, and/or ...
This is called a relapse. Sometimes the relapse happens years later. Some people may have multiple relapses. By Mayo Clinic Staff.
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
... relapse. The cohorts will start in parallel and independently. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.